22 November 2017 - Agrees joint work plan with the European Network for Health Technology Assessment.
The EMA has extended a partnership with the organisation representing Europe’s health technology assessment (HTA) bodies, aimed at improving access to medicines, for another three years.
The agreement of a joint work plan between the EU regulator and the European Network for Health Technology Assessment (EUnetHTA) for 2017-2020 will take the collaboration between the two organisations - which has the goal of improving the efficiency and quality of assessment processes - out to the 10-year mark.
Among the highlights of the work plan is a new joint platform for parallel consultation, which was set up in the summer to allow drug developers to get advice from the EMA and HTAs such as the UK’s National Institute for Health and Care Excellence (NICE) in parallel rather than sequentially.